Skip to main content

National Cancer Institute — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

102
Companies
$325.9M
Total invested
$3.4M
Avg. check
21
Industries
Biotechnology 19Health Care 17Medical 9Therapeutics 8Pharmaceutical 7Medical Device 4+15 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 49–72 of 102
Flexomics
July 2022

Flexomics helps to bridge genomic and functional analysis.

Biotechnology · Boston$2.0M Grant
Atrin Pharmaceuticals
July 2022

Atrin Pharmaceuticals is a privately held biopharmaceutical company that aims to change the way cancer is being treated.

Biotechnology · DoylestownSeries A
Immunicom
June 2022

Immunicom is a biotechnology company.

Biotechnology · San Diego$2.0M Grant
InheRET
May 2022

InheRET empowering individuals to accurately identify their risk for hereditary conditions.

Health Care · Ann Arbor$580K Seed
Symple Surgical
February 2022

Symple Surgical is a medical device company focusing on developing novel therapeutic technologies through controlled microwave ablation.

Health Care · Flagstaff$400K Grant
Veana Therapeutics
January 2022

Veana Therapeutics is a Biotechnology Company based in Oregon.

Biotechnology · Portland$50K Grant
Shasqi
December 2021

Pioneering in-human click chemistry against cancer

Biotechnology · San Francisco$1.9M Grant
TumorGen
August 2021

TumorGen is a biotechnology company.

Biotechnology · San Diego$390K Grant
Advanced Chemotherapy Technologies
August 2021

Advanced Chemotherapy Technologies is a startup developing a device that can infuse chemotherapies into poorly vascularized tumors.

Health Care · Raleigh$4.0M Grant
Linnaeus Therapeutics
February 2026

Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.

Biotechnology · Haddonfield$22.0M Grant
Trethera
December 2025

Trethera is a biotechnology company that discovers and develops small molecules that control DNA replication and integrity.

Biotechnology · Beverly Hills$2.7M Grant
Paramita Therapeutics
November 2025

Paramita Therapeutics is a biotech company that focuses on developing new cancer and infectious disease therapeutics.

Biotechnology · San Diego$353K Grant
RIVANNA
October 2025

RIVANNA commercializes ultrasound technologies that reduce the patient risk caused by radiation from X-ray-based medical imaging.

Biotechnology · Crozet$3.0M Grant
Veramorph
October 2025

VeraMorph is a pharmaceutical company that is developing an oral dosage technology based on polymers.

Biotechnology · MansfieldGrant
Transcode Therapeutics
October 2025

TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.

Biotechnology · Newton$20.0M Post Ipo Equity
QT Imaging
October 2025

QT Imaging is a scanning center that provides breast imaging by tomographic transmission ultrasound for patients.

Health Care · Novato$18.0M Post Ipo Equity
Allterum Therapeutics
September 2025

Allterum Therapeutics is a biopharmaceutical company that develops treatments for different types of cancers.

Biopharma · Houston$1.0M Grant
Navrogen
September 2025

Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.

Biotechnology · PhiladelphiaGrant
MetasTx LLC
July 2025

MetasTx is creating treatments that prevent and treat prostate cancer metastasis without affecting the Androgen System.

Manufacturing · Basking Ridge$400K Grant
Quiver Bioscience
July 2025

Quiver Bioscience develops medicines for brain disorders using human disease models and AI to advance drug development.

Artificial Intelligence (AI) · CambridgeGrant
Lamassu Pharma
June 2025

Lamassu Pharma is a biotech startup that solves the critical unmet medical need for severe acute pancreatitis.

Biotechnology · Durham$2.7M Grant
Tiga TX
December 2024

Tiga TX develops an IgA therapeutic monoclonal antibody platform for the treatment of solid tumors.

Biotechnology · Boston$35.5M Grant
Palm Therapeutics
September 2024

Palm Therapeutics is a next-generation therapeutics company to cure cancer at its source.

Biotechnology · San Diego$250K Grant
Xylyx Bio
September 2024

Xylyx Bio creates effective science-based solutions for the benefit of human life and health.

Biotechnology · Brooklyn$2.5M Grant

Where National Cancer Institute invests

Biotechnology19
Health Care17
Medical9
Therapeutics8
Pharmaceutical7
Medical Device4

About National Cancer Institute's portfolio

How many companies has National Cancer Institute invested in?▸

National Cancer Institute has invested in 102 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does National Cancer Institute invest in?▸

National Cancer Institute's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 21 different industry categories.

What is National Cancer Institute's largest investment?▸

Among tracked funding rounds, Tiga TX received $35.5M in a Grant round. National Cancer Institute's total known invested capital is $325.9M.

What is the average investment size for National Cancer Institute?▸

National Cancer Institute's average investment size is $3.4M across its portfolio of 102 companies.

What are National Cancer Institute's most recent investments?▸

Recent National Cancer Institute portfolio additions include Flexomics, Atrin Pharmaceuticals, Immunicom, InheRET, Symple Surgical. These companies were founded in 2020 or later.

Reach the founders behind these 102 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →